These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 20427625)

  • 21. Identification of SP1683 as a pneumococcal protein that is protective against nasopharyngeal colonization.
    Moens L; Hermand P; Wellens T; Wuyts G; Derua R; Waelkens E; Ysebaert C; Godfroid F; Bossuyt X
    Hum Vaccin Immunother; 2018 May; 14(5):1234-1242. PubMed ID: 29400602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nasopharyngeal carriage with Streptococcus pneumoniae augments the immunizing effect of pneumolysin toxoid B.
    Neill DR; Smeaton S; Bangert M; Kadioglu A
    J Allergy Clin Immunol; 2013 May; 131(5):1433-5.e1. PubMed ID: 23260752
    [No Abstract]   [Full Text] [Related]  

  • 23. Mechanisms in the serotype-independent pneumococcal immunity induced in mice by intranasal vaccination with the cell wall polysaccharide.
    Lu YJ; Skovsted IC; Thompson CM; Anderson PW; Malley R
    Microb Pathog; 2009 Sep; 47(3):177-82. PubMed ID: 19577628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired innate and adaptive immunity to Streptococcus pneumoniae and its effect on colonization in an infant mouse model.
    Bogaert D; Weinberger D; Thompson C; Lipsitch M; Malley R
    Infect Immun; 2009 Apr; 77(4):1613-22. PubMed ID: 19168741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Host immunity in the protective response to nasal immunization with a pneumococcal antigen associated to live and heat-killed Lactobacillus casei.
    Vintiñi EO; Medina MS
    BMC Immunol; 2011 Aug; 12():46. PubMed ID: 21834957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intranasal vaccination with chitosan-DNA nanoparticles expressing pneumococcal surface antigen a protects mice against nasopharyngeal colonization by Streptococcus pneumoniae.
    Xu J; Dai W; Wang Z; Chen B; Li Z; Fan X
    Clin Vaccine Immunol; 2011 Jan; 18(1):75-81. PubMed ID: 21047997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multivalent Pneumococcal Protein Vaccines Comprising Pneumolysoid with Epitopes/Fragments of CbpA and/or PspA Elicit Strong and Broad Protection.
    Chen A; Mann B; Gao G; Heath R; King J; Maissoneuve J; Alderson M; Tate A; Hollingshead SK; Tweten RK; Briles DE; Tuomanen EI; Paton JC
    Clin Vaccine Immunol; 2015 Oct; 22(10):1079-89. PubMed ID: 26245351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Salmonella outer membrane vesicles displaying high densities of pneumococcal antigen at the surface offer protection against colonization.
    Kuipers K; Daleke-Schermerhorn MH; Jong WS; ten Hagen-Jongman CM; van Opzeeland F; Simonetti E; Luirink J; de Jonge MI
    Vaccine; 2015 Apr; 33(17):2022-9. PubMed ID: 25776921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucosal immunization with recombinant fusion protein DnaJ-ΔA146Ply enhances cross-protective immunity against Streptococcus pneumoniae infection in mice via interleukin 17A.
    Liu Y; Wang H; Zhang S; Zeng L; Xu X; Wu K; Wang W; Yin N; Song Z; Zhang X; Yin Y
    Infect Immun; 2014 Apr; 82(4):1666-75. PubMed ID: 24491576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers.
    Stephenson I; Zambon MC; Rudin A; Colegate A; Podda A; Bugarini R; Del Giudice G; Minutello A; Bonnington S; Holmgren J; Mills KH; Nicholson KG
    J Virol; 2006 May; 80(10):4962-70. PubMed ID: 16641287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intranasal Immunization with the Commensal
    Shekhar S; Khan R; Schenck K; Petersen FC
    Appl Environ Microbiol; 2019 Mar; 85(6):. PubMed ID: 30683742
    [No Abstract]   [Full Text] [Related]  

  • 32. Dendritic cell-targeting DNA-based nasal adjuvants for protective mucosal immunity to Streptococcus pneumoniae.
    Kataoka K; Fukuyama Y; Briles DE; Miyake T; Fujihashi K
    Microbiol Immunol; 2017 Jun; 61(6):195-205. PubMed ID: 28463465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The adjuvant double mutant Escherichia coli heat labile toxin enhances IL-17A production in human T cells specific for bacterial vaccine antigens.
    Leach S; Clements JD; Kaim J; Lundgren A
    PLoS One; 2012; 7(12):e51718. PubMed ID: 23284753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae.
    Briles DE; Hollingshead SK; Nabors GS; Paton JC; Brooks-Walter A
    Vaccine; 2000 Dec; 19 Suppl 1():S87-95. PubMed ID: 11163470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Construction and immunological characterization of a novel nontoxic protective pneumolysin mutant for use in future pneumococcal vaccines.
    Kirkham LA; Kerr AR; Douce GR; Paterson GK; Dilts DA; Liu DF; Mitchell TJ
    Infect Immun; 2006 Jan; 74(1):586-93. PubMed ID: 16369015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gamma-irradiation of Streptococcus pneumoniae for the use as an immunogenic whole cell vaccine.
    Jwa MY; Jeong S; Ko EB; Kim AR; Kim HY; Kim SK; Seo HS; Yun CH; Han SH
    J Microbiol; 2018 Aug; 56(8):579-585. PubMed ID: 30047087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Phase 1 Randomized, Placebo-controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of Inactivated Streptococcus pneumoniae Whole-cell Vaccine in Adults.
    Keech CA; Morrison R; Anderson P; Tate A; Flores J; Goldblatt D; Briles D; Hural J; Malley R; Alderson MR
    Pediatr Infect Dis J; 2020 Apr; 39(4):345-351. PubMed ID: 31895881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intranasal vaccination with γ-irradiated Streptococcus pneumoniae whole-cell vaccine provides serotype-independent protection mediated by B-cells and innate IL-17 responses.
    Babb R; Chen A; Hirst TR; Kara EE; McColl SR; Ogunniyi AD; Paton JC; Alsharifi M
    Clin Sci (Lond); 2016 May; 130(9):697-710. PubMed ID: 26831937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucosal immunization with polyamine transport protein D (PotD) protects mice against nasopharyngeal colonization with Streptococcus pneumoniae.
    Shah P; Briles DE; King J; Hale Y; Swiatlo E
    Exp Biol Med (Maywood); 2009 Apr; 234(4):403-9. PubMed ID: 19176871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunization with a combination of three pneumococcal proteins confers additive and broad protection against Streptococcus pneumoniae Infections in Mice.
    Wu K; Zhang X; Shi J; Li N; Li D; Luo M; Cao J; Yin N; Wang H; Xu W; He Y; Yin Y
    Infect Immun; 2010 Mar; 78(3):1276-83. PubMed ID: 20038538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.